2020.12
CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s
CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceut...
2020.12
NIP Pharm received the clinical trial approval of innovative drug NIP046
NIP Pharm received the clinical trial approval of innovative drug NIP046
2020.02
CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA
CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA
2017.08
Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceutical Industry in 2016”
Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceut...
2017.06
CR Pharma is officially included in the FTSE global equity index
CR Pharma is officially included in the FTSE global equity index
2017.08
China Resources Pharmaceutical Delivers Solid Interim Results
China Resources Pharmaceutical Delivers Solid Interim Results
2017.06
CR Pharma Releases Sustainable Development Report 2016
CR Pharma Releases Sustainable Development Report 2016